Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VMX-C001 study in healthy volunteers
NL-OMON59930Phase 1Completed
- Sponsor
- VarmX
- Start
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, single-arm trial of VMX-C001 in anticoagulant reversal, sponsored by VarmX. Started Aug 2024; status: completed.
02
Drugs
VMX-C001
03
Conditions
anticoagulant reversal
Beyond the preview
Go deeper on NL-OMON59930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59930.